David H. Wagner
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$3.9MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $3.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Dec 31, 2019 | NIH | STTR Phase II Developing a Small Peptide to Control Autoimmune Inflammation In Type 1 Diabetes | $765K | Op-T-Mune, Inc |
| Jul 30, 2019 | NIH | STTR Phase II Development of a Clinical Screening Platform for Type 1 Diabetes | $594K | Op-T-Mune, Inc |
| Dec 18, 2018 | NIH | STTR Phase II Developing a Small Peptide to Control Autoimmune Inflammation In Type 1 Diabetes | $1.0M | Op-T-Mune, Inc |
| Sep 18, 2018 | NIH | STTR Phase II Development of a Clinical Screening Platform for Type 1 Diabetes | $561K | Op-T-Mune, Inc |
| Jul 26, 2017 | NIH | STTR Phase I Screening for the autoimmune component of multiple sclerosis | $299K | Op-T-Mune, Inc |
| Jul 17, 2017 | NIH | STTR Phase II Development of a Clinical Screening Platform for Type 1 Diabetes | $421K | Op-T-Mune, Inc |
| Feb 15, 2017 | NIH | STTR Phase I Developing a small peptide to control autoimmune inflammation in type 1 diabetes | $297K | Op-T-Mune, Inc |
Peer ranks
Federal funding#406
Awards as PI#250
Patents#273
Companies
- Op-T-Mune, IncLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.